NCT01304329View on ClinicalTrials.gov

Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Conditions
Healthy
Interventions
DRUG

BI 10773

Medium dose oral administration

DRUG

simvastatin

Medium dose oral administration

DRUG

simvastatin

Medium dose oral administration

DRUG

BI 10773

Medium dose oral administration

Trial Locations (1)

Unknown

1245.63.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01304329 - Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin | Biotech Hunter | Biotech Hunter